HK-based Insilico Medicine recently raised US$ 255m, and is disrupting the pharma industry with its novel use of deep learning and AI.
( read original story …)
The HongKong News
HK-based Insilico Medicine recently raised US$ 255m, and is disrupting the pharma industry with its novel use of deep learning and AI.
( read original story …)